Markets & Regulations

Janssen recruits AI startup to develop blood cancer treatments

Janssen recruits AI startup to develop blood cancer treatments

By Jonathan Smith

The UK startup Intelligent OMICS (Intellomx) has launched a collaboration with Johnson & Johnson’s pharmaceutical company Janssen to use artificial intelligence (AI) to discover drug targets for the treatment of blood cancer.

© Getty Images

Danaher acquires Abcam shares in deal worth $5.7BN

By Liza Laws

Danaher is to acquire Abcam for $24 per share - a total enterprise value of approximately $5.7 billion representing approximately 40% more than Abcam's undisclosed share prices in May.

© Getty Images

Further investment for BDD Pharma after £2M funding round

By Liza Laws

Integrated drug formulation and clinical trials company, BDD Pharma, will be expanding its phase appropriate development, manufacturing, and clinical testing services after a £2 million ($1.3 million) investment.

© Getty Images

New appointments: Who are the movers and shakers in pharma?

By Isabel Cameron

BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers and shakers in the pharma industry. From Karuna Therapeutics to IO Biotech, we break down the key changes on the pharmaceutical job ladder.

© Getty Images

AARDEX Group named founding member of CancerX initiative

By Isabel Cameron

Adherence specialist AARDEX Group has been announced as a founding member of the CancerX initiative, which aims to bring diverse stakeholders together to drive innovation and improve follow up for cancer patients.

© Getty Images

Big pharma companies team up to increase diversity in genome data

By Jonathan Smith

The pharma giants AbbVie, Amgen, AstraZeneca, Bayer and Merck have been revealed as founding members of the Alliance for Genomic Discovery (AGD), a project aiming to accelerate drug development by collecting genomic data from underrepresented populations.

© Getty Images

Convatec to manufacture new infusion set for Tandem Diabetes Care

By Isabel Cameron

Convatec Group, a medical products and technologies company focused on chronic conditions, has partnered with Tandem Diabetes Care on a new five-inch infusion set for Tandem Mobi, the world’s smallest durable automated insulin delivery system.